Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Apr 26 2023

Full Issue

Sanders And Cassidy Agree On Targeting PBMs In Drug Costs Bill

News outlets report on political progress made during bipartisan efforts to boost access to generic drugs, with a goal of increasing transparency demands on PBMs. Separately, a Medicare official has insisted drug price negotiations will include how important a drug is to patients.

Stat: Sens. Bernie Sanders, Bill Cassidy Reach Deal On PBM, Generic Reform

Senate health committee leaders Bernie Sanders and Bill Cassidy on Tuesday announced an agreement on a bipartisan package to increase access to generic drugs and increase the transparency required of pharmacy middlemen. (Cohrs, 4/25)

Modern Healthcare: Sanders, Cassidy Target PBMs In New Senate Bill

The pressure on pharmacy benefit managers mounts on Capitol Hill as the leaders of the Senate health committee unveiled the latest bills targeting prescription drug costs on Tuesday. (Tepper and Nzanga, 4/25)

On Medicare drug price negotiation —

Stat: Medicare Official Insists Drug Price Negotiation Will Consider Value

When Medicare starts negotiating drug prices, it will take into account how important a drug is for patients, Meena Seshamani, the director of the Center for Medicare, said Tuesday. (Wilkerson, 4/25)

In other news from Capitol Hill —

AP: More Sanctions For Deadly Fentanyl If Bill Becomes Law 

Over the past year, the U.S. Treasury Department has used its sanctions powers to impose wide-ranging financial penalties on Russia in response to its invasion of Ukraine — turning Russia into the most sanctioned country in the world. Now, the federal agency is facing increasing pressure, including from legislation introduced Tuesday in the Senate, to use those tools with similar vigor against the people, financial institutions and companies that have participated in the explosion of fentanyl use and distribution in the U.S. (Hussein, 4/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF